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Abstract We found that exposure to room temperature (RT/ 
21 °C) causes apoptosis in HL-60 cells. Here we characterized 
RT-induced apoptosis in HL-60. After exposure to RT, apoptosis 
starts within 6 h and more than 80% of the cells underwent 
apoptosis within 20 h. All cells, however, were committed to 
apoptosis after 16 h and no viable cells could be recovered. The 
caspase-1 inhibitor (YVAD-CHO) effectively blocked apoptosis, 
whereas the caspase-3 inhibitor (DEVD-CHO) did not. About 
20% of newly obtained early passage HL-60 cells (passage 10) 
also underwent apoptosis by RT treatment. These data suggest 
that some population in HL-60 which responds to RT with 
apoptosis became dominant during passaging. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Apoptosis is an active process of cell death accompanied by 
cytoplasmic shrinkage, membrane blebbing, nuclear fragmen-
tation and internucleosomal D N A cleavage ( D N A ladder) [1]. 
There seem to exist three phases in the process leading to 
apoptosis [2]. The first phase is the triggering of signal trans-
duction which is caused by a variety of inducers including an 
antibody or a ligand to cell surface receptors (Fas/APO-1 or 
TNF-oc) [3] and D N A damaging agents [4] as well as inhib-
itors of the micro tubule function [5]. The activation of intra-
cellular cascades composed of various caspases is the second 
phase. Since interleukin-1 converting enzyme (ICE) (now re-
named caspase-1) [6] was first proposed as a mammalian ho-
mologue of CED-3 of Caenorhabditis elegans [7], more than 10 
cysteine proteases have been cloned and analyzed [3]. Among 
these caspases, caspase-3 (CPP32) has been well characterized 
and seems to be placed in the central pathway of the apop-
totic process [8-11]. Because caspase-3 shows the highest ho-
mology to CED-3 [12] and its tetrapeptide inhibitor (DEVD-
CHO) often blocks apoptosis induced by a variety of inducers 
[13,14], it is now thought to be a human equivalent of CED-3 
[12]. The third phase of the apoptotic process is a cleavage of 
macromolecules including so-called death substrates such as 
poly(ADP-ribose) polymerase (PARP) [15], Ul-smal l nuclear 
ribonucleoprotein [16], DNA-dependent protein kinases [17], 
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fodrin [18] and lamins [19]. These death substrates are sequen-
tially cleaved according to the process of apoptosis [20]. It is, 
however, still unclear if cleavages of these death substrates are 
crucial for apoptosis. 
HL-60 is a myelogenous leukemia cell line [21] widely used 
for studying the mechanism of apoptosis. A variety of com-
pounds was used for inducing apoptosis including R N A and 
protein synthesis inhibitors, topoisomerase inhibitors and pro-
tein kinase inhibitors [22-26]. Recently, Saeki et al. reported 
that conditioned medium of confluent HL-60 contained hu-
moral factor(s) which induces apoptosis in HL-60 itself [27]. 
Faleiro et al. reported that caspases-3 and -6 (Mch2) are ma-
jor cysteine proteases active in the apoptosis of leukemia cell 
lines including HL-60 [28]. A recent report by Polverino et al. 
showed that caspase-3 but not caspase-1 was cleaved to its 
active form in HL-60 when treated with a protein synthesis 
inhibitor [23]. Although caspase-3 seems to be more effective 
than caspase-1 for apoptosis in HL-60, the crucial caspase(s) 
in each apoptotic event remains to be clarified. 
Here we report that simple exposure of HL-60 to room 
temperature (RT, 21°C) induces apoptosis. Interestingly, 
apoptosis in HL-60 responding to R T is efficiently blocked 
by the caspase-1 inhibitor (YVAD-CHO), whereas it is not 
blocked by the caspase-3 (DEVD-CHO) , suggesting that R T 
treatment could possibly provide a system to study the bio-
logical significance of caspase-1 or caspase-1-like protease ac-
tivity in apoptosis. 
2. Materials and methods 
2.1. Cell lines and RT treatment 
The human myelogenous cell line, HL-60, was from our frozen 
stock. Since its passage number was unfortunately unclear, addition-
ally a new HL-60 cell line (passage 10) was obtained from the Health 
Science Research Resources Bank (JCRB0085). Most of the experi-
ments were performed using HL-60 from our frozen stock. Cells were 
maintained in RPMI 1640 (Life Tech Oriental) supplemented with 
10% fetal calf serum (Bio Whittaker, MA) at 37°C in 5% C0 2 . To 
expose cells to RT, 2 ml of 2-4Xl05/ml cells was transferred to 
culture tubes (Nunc, Nippon Intermed Co.) and incubated at 37°C, 
until the medium pH was equilibrated. Then, the cap of each tube was 
tightly closed and the cells were placed at RT. Cells were usually 
recovered for analysis after 12 h. 
2.2. Caspase inhibitors 
Caspase-1 and -3 inhibitors were purchased from Wako Co. and 
Peptide Institute Inc., respectively. The amino acid sequences of in-
hibitors of caspases-1 and -3 are YVAD-CHO and DEVD-CHO, 
respectively. Each peptide had formaldehyde on the carboxy-terminal 
amino acid. Peptides were dissolved in dimethylsulfoxide (DMSO) 
(Wako Co.) and 100 JAM peptide was added to the cell suspension 
with a final concentration of 0.3% DMSO. As a control, 0.3% DMSO 
was added to a culture. 
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2.3. FACS analysis 
FACS analysis has been proposed as a versatile method to detect 
apoptotic cells as a hypodiploid DNA peak (sub-Gl) [29]. In the 
present study we used FACS analysis for evaluation of apoptotic cells. 
After exposure to RT, cells were centrifuged at about 200 X g, washed 
once in PBS, then resuspended in 70%o ice-cold ethanol for fixing. 
After treatment with RNase A (100 ug/ml) (Sigma, St. Louis, MO) 
for 30 min at 37°C, DNA was stained with 50 ug/ml of propidium 
iodide (Sigma). Cell cycle analysis was performed by FACScan (Nip-
pon Becton Dickinson Co., Japan) and the number of cells in the area 
corresponding to the sub-Gl region was calculated using the Lysis II 
program (Becton Dickinson Co.). 
2.4. Extraction of DNA and analysis of DNA ladder 
DNA was extracted according to the method described by Yin et al. 
[30]. Briefly, about 107 cells were washed in PBS, then resuspended in 
lysis buffer (10 mM Tris-HCl, 10 mM EDTA and 0.2% Triton X-100, 
pH 7.5). Cells were placed on ice for 10 min, then centrifuged at 
16000Xg for 10 min. The supernatant was transferred to a new 
tube and extracted once with a phenol:chloroform:isoamyl alcohol 
(24:24:1) solution. To the aqueous phase NaCl was added to make 
the final concentration 300 mM. Nucleic acid was precipitated by 
2 volumes of ethanol. After centrifugation, the pellet was washed 
with 70%> ethanol, then resuspended in 50 jul of solution with 10 mM 
Tris-HCl (pH 8.0) and 1 mM EDTA. RNA was digested with RNase 
A (100 |xg/ml), then 10 ul of each sample was loaded on agarose gel 
composed of 1% agarose (Gibco BRL, New York) and 1% NuSieve 
GTG agarose (FMC, Maine). DNA was visualized by ethidium bro-
mide staining. 
2.5. Detection of nuclear fragmentation 
Cells were fixed in a solution containing acetone and methanol 
(3:1), then stained with 4 ug/ml Hoechst 33342 (Sigma). Stained cells 
were examined with a fluoromicroscope (Olympus). Cells showing 
nuclear fragmentation were judged to be apoptotic. 
2.6. MTT assay 
Recovery of cell growth after RT treatment was assayed by colori-
metric assay using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazo-
lium bromide (MTT) (Sigma), as described [31]. Cells (2xlOB/ml) 
were returned to conventional culture conditions (37°C and 5% 
CO2) after RT treatment. On day 4 after exposure to RT each 100 
ul of cell suspension was incubated with 5 mg/ml MTT at 37°C until 
MTT formazan was detected as fuzzy crystals. Absorbance at 570 nm 
was measured using a microplate reader (Model 3550, Bio-Rad). 
3. Results 
3.1. RT-induced apoptosis in HL-60 
FACS analysis detected an increased population corre-
sponding to sub-Gl after RT treatment (Fig. 1A, lower left 
panel). About 60% of the cell population was detected in this 
region. In contrast the U937 cell line did not show any in-
crease in the sub-Gl population (Fig. 1A, lower right panel). 
To determine whether this increment of sub-Gl detected in 
HL-60 is due to apoptosis or necrosis, DNA-ladder formation 
in the cells was analyzed. Fig. IB shows that DNA extracted 
from RT-treated cells contained DNA ladders. Also Hoechst 
33342 staining detected nuclear fragmentation in about 70% 
of the cells (Fig. 1C, right panel). Trypan blue staining indi-
cated that almost 100% of the cells were viable after RT treat-
ment. Based on these findings we concluded that the increase 
in the population of the sub-Gl region detected by FACS 
analysis is due to increased apoptotic cells and not to necrotic 
cells. 
The factors influencing apoptosis were studied. Fig. 2A 
shows the time course of RT-induced apoptosis. Apoptosis 
started within 6 h and more than 80% of cells underwent 
apoptosis within 20 h. The effects of temperature (Fig. 2B) 
on apoptosis were also studied. About 50 and 30% of the cells 
were detected as apoptotic cells at 25 and 29°C, respectively. 
Induction of apoptosis at 33°C was greatly reduced (10%). 
Apoptosis was not detected at 4°C, suggesting that an appro-
priate temperature is necessary for the enzyme reaction to 
complete apoptosis. Next we assayed the ability of cells to 
recover after exposure to RT. The MTT assay was performed 
on day 4 after exposure to RT. A representative result is 
shown in Fig. 2C. The recovery of cells, when exposed for 
more than 12 h, was greatly reduced. Cells treated for 16 or 24 
h did not recover at all, suggesting that 100% of the cells were 
committed to apoptosis during the first 16 h. 
3.2. Effects of caspase-1 and -3 inhibitors on RT-induced 
apoptosis 
To approach the molecular mechanism of RT-induced 
apoptosis we studied the effects of the inhibitors of casp-
ases-1 and -3. The inhibitors are composed of tetrapeptides 
modified with formaldehyde on the carboxy-terminal residue. 
Both peptides, YVAD-CHO and DEVD-CHO, are well ac-
cepted as specific inhibitors to caspase-1 [3] and caspase-3 [12], 
respectively. A representative result of three independent ex-
periments is shown in Fig. 3A. DMSO used as a solvent of 
peptide inhibitor slightly reduced the sub-Gl population from 
63%) to 43%) (Fig. 3A, upper and lower left panels). The effect 
of YVAD-CHO peptide was striking, reducing the sub-Gl 
population to 11% (Fig. 3A, upper right panel). In an inde-
pendent experiment the effect of different doses of the peptide 
was studied. When 25, 50 and 100 \iM peptide were used, the 
population of sub-Gl was reduced to 34, 22 and 10%> from 
46%> observed in RT-treated HL-60 (data not shown). This 
result indicates that RT-induced apoptosis is sensitive to 
YVAD-CHO peptide in a dose-dependent manner. 
On the other hand, DEVD-CHO did not change the num-
ber of apoptotic cells (Fig. 3A, lower right panel). To exclude 
the possibility that the DEVD-CHO used in the present study 
had no biological activity, the same peptide was incubated in 
Table 1 
Effects of the caspase-1 and -3 inhibitors on apoptosis of HL-60 induced by etoposide and ionomycin 
Caspase inhibitor 
YVAD-CHO 
DEVD-CHO 
Treatment 
Etoposide" 
+ 
Ionomycinb 
— 
Room temperature 
+ 
BHL-60 cells were preincubated for 30 min in the presence of etoposide (5 ug/ml) (Sigma), then returned to normal culture conditions. After 6 h, 
cells were fixed and subjected to FACS analysis. After etoposide treatment about 23%o of cells were detected in the sub-Gl region. Addition of 
caspsase-1 inhibitor decreased the population in the sub-Gl region to about 6%. 
bCells were incubated for 8 h in the presence of ionomycin (0.5 ug/ml) (Sigma), then subjected to FACS analysis. About 30%. of cells were detected 
in the sub-Gl region after treatment with ionomycin. 
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Fig. 1. RT-induced apoptosis of HL-60. FACS analysis of HL-60 and U937 after RT treatment for 12 h (A). The population in the sub-Gl re-
gion is indicated. DNA-ladder formation in HL-60 cells treated with RT (B). DNA extracted from cells placed at RT (left panel) and 37°C 
(right) was analyzed. 'M' denotes the molecular weight marker of 100 bp ladders (Gibco). Demonstration of nuclear fragmentation in HL-60 
after RT treatment (C). Morphology of HL-60 cultured at 37°C (left panel) and RT (right panel) is shown. 
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Fig. 2. Factors influencing RT-induced apoptosis. Time course of apoptosis (A). Hatched and solid boxes indicate apoptosis of cells cultured at 
RT and at 37°C, respectively. The population in the sub-Gl region detected by FACS analysis was plotted as a function of the incubation peri-
od. The effects of various temperatures on the induction of apoptosis (B). The method was similar to that described in A. The recovery of cell 
growth after treatment of RT (C). On day 4 after RT treatment, the cell number was calculated using the MTT assay. Absorbance at 570 nm 
of the control sample was considered 100% and % recovery was calculated. ND, not detected. 
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Fig. 3. The effects of caspase inhibitors on RT-induced apoptosis. The change in apoptosis by caspase-1 and -3 inhibitors (A). The effect of 
100 uM of peptide inhibitor on RT-induced apotosis was studied. As a control, the effect of 0.3% DMSO used as a solvent of each peptide 
was also studied (lower left panel). In this experiment cells were exposed to RT for 8 h. The effect of the peptide inhibitor to caspase-3 on 
apoptosis of U937 induced by TNF-a (B). 
a culture of U937 cells incubated with TNF-a (1 ng/ml). As 
shown in Fig. 3B, TNF-a increased the sub-Gl population 
from 3% to 24% (Fig. 3B, upper left and right panels). The 
caspase-1 and -3 inhibitors reduced the population in the sub-
Gl region to 6 and 9%, respectively (Fig. 3B, lower left and 
right panels). This finding is consistent with a previous report 
that TNF-a-induced apoptosis involves both caspases-1 and 
-3 [3]. The result clearly indicates that DEVD-CHO peptide is 
biologically active and that RT-induced apoptosis is insensi-
tive to the caspase-3 inhibitor. 
To clarify the biological significance of caspases-1 and -3 in 
HL-60 apoptosis, we studied the effects of these inhibitors on 
apoptosis caused by other agents. The agents included etopo-
side, a DNA damaging agent [4], and ionomycin, a calcium 
ionophore [32]. The results are summarized in Table 1. Treat-
ment with etoposide caused about 23% of HL-60 cells to 
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Fig. 4. RT-induced apoptosis in a new HL-60 cell line at passage 
number 10. Cells were treated at RT for 12 h (lower panel). 
undergo apoptosis. Addition of YVAD-CHO decreased the 
population in the sub-Gl region to about 6%. On the other 
hand, addition of DEVD-CHO did not change the population 
in the sub-Gl region. In ionomycin-induced apoptosis both 
caspase-1 and -3 inhibitors had no effects. These results sug-
gest that the caspase-1 or caspase-1-like protease was involved 
in the apoptotic process induced by etoposide as well as RT 
treatment. The signals induced by RT treatment and etopo-
side possibly share a common cascade in the apoptotic proc-
ess. Although caspase-3 does not seem to work as a central 
player in the apoptosis induced by RT treatment, etoposide 
and ionomycin, it has been reported that anisomycin, a pro-
tein synthesis inhibitor, induced apoptosis in HL-60 with the 
activation of caspase-3 [22]. It is likely that a variety of sets of 
caspases are involved according to the agents triggering apop-
tosis. 
We tried to study directly whether caspases-1 and -3 were 
involved in RT-induced apoptosis. It has been reported that 
the 45 kDa precursor protein of caspase-1 is processed to p20 
and plO by activation [33]. Also the 32 kDa protein of cas-
pase-3 is cleaved to its active forms composed of pl2 and pl7 
subunits [12]. Western blot analysis was performed on the cell 
extract obtained after 12 h treatment at RT and the blots were 
probed with antibodies to caspases-1 and -3. Activated forms 
of these caspases, however, were not detected (data not 
shown). 
3.3. RT-induced apoptosis in a newly obtained HL-60 cell line 
To exclude the possibility that RT-induced apoptosis is ob-
served only in our HL-60 stock, we obtained the same cell line 
from a cell bank and studied the apoptosis by RT treatment. 
As shown in Fig. 4, the newly obtained HL-60 also showed 
the increase of population in the sub-Gl region (lower panel). 
About 20% of the cells were located in the sub-Gl region after 
a 12 h exposure to RT. Microscopic examination after RT 
treatment confirmed the generation of membrane Webbings 
and apoptotic body formation (data not shown). The fre-
quency of cell death was rather low compared to the HL-60 
of our stock, suggesting that during passaging populations 
responding to RT with apoptosis have become dominant. 
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4. Discussion 
In the present report we showed a simple and efficient RT-
induced apoptosis of HL-60 which is sensitive to the caspase-1 
inhibitor but not to the caspase-3 inhibitor. Western blot 
analysis could not detect the processing of caspase-1, suggest-
ing that caspase-1-like protease is involved in RT-induced 
apoptosis. Using this system it may be possible to characterize 
a novel caspase. Also the physiological role of caspase-1-like 
protease could be analyzed. 
Now we cannot point out a causative factor of RT-induced 
apoptosis. As one of the candidates it is possible to note that 
the difference of oxygen consumption at RT generates reactive 
oxygen. There are reports that reactive oxygen acts as an 
inducer of apoptosis [34-36]. Peroxynite, a physiological prod-
uct produced by the reaction of superoxide and nitrite oxide, 
produces superoxide anion inducing apoptosis in HL-60 [35]. 
Generation of reactive oxygen was proposed as a crucial step 
also in dexamethasone-induced apoptosis [36]. In the present 
work, DMSO, a hydroxy radical scavenger [37,38], slightly 
suppressed RT-induced apoptosis (Fig. 3A), suggesting the 
involvement of reactive oxygen in RT-induced apoptosis. 
We are focusing on the role of reactive oxygen production 
in RT-induced apoptosis which seems to be a quick biochem-
ical response to RT treatment. 
Here, for the first time, we characterized RT-induced apop-
tosis in a single cell line of HL-60. It is likely, however, that 
other cell lines also respond to RT. So far we have studied 
RT-induced apoptosis in more than 10 human cell lines and 
found that a T-cell lineage underwent apoptosis by RT treat-
ment. Interestingly, the mode of sensitivity to caspase inhib-
itors in this cell line is different from that of HL-60 (M. 
Shimura, unpublished data). Using these two cell lines it is 
possible to clarify the redundant pathways of the apoptotic 
process induced by the same trigger. Such information would 
be useful for understanding the complexity of the apoptotic 
process. More importantly, there might be leukemia cases in 
which leukemic cells undergo apoptosis when exposed to RT. 
The simple procedure of RT treatment might be a new strat-
egy to eliminate leukemic cells in such cases. 
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